Momentum investing sounds like a physics law and behaves like a mood ring. The iShares MSCI USA Momentum Factor ETF (BATS:MTUM) has ridden the AI-chip surge to a 29% year-to-date gain through July 6, but the fund just took its worst weekly hit of the year, dropping nearly 7% in the seven days ending July 2.
That is the tell. MTUM owns whatever ran hardest into the last rebalance, and right now what ran hardest was semiconductors. If July delivers the rotation everyone keeps whispering about, MTUM is the ETF that gets hurt first.
What momentum actually buys you
MTUM tracks the MSCI USA Momentum SR Variant Index, which ranks large and mid-cap U.S. stocks on risk-adjusted price performance over six and twelve months, then rebalances twice a year. You pay 0.15% in annual expenses to own whatever the trend spit out. It is a rules-based way to chase winners without the emotional whiplash of doing it yourself. The edge is real. The trap is that the fund cannot see around corners, so it concentrates into last quarter’s story right as the next quarter arrives.
Look at the current book. As of the top five positions are Micron (NASDAQ:MU | MU Price Prediction), AMD (NASDAQ:AMD), Intel (NASDAQ:INTC), Broadcom (NASDAQ:AVGO), and Catepillar (NYSE:CAT). Add Lam Research (NASDAQ:LRCX) and Applied Materials (NASDAQ:AMAT) and you get roughly 33% of a $27 billion fund parked in semiconductors. This is a chip fund wearing a factor label.
Does the strategy deliver
Over the trailing year, MTUM returned about 36%, and over five years it delivered about 96%. Strong on the surface, but path-dependent. The catch is path dependency.
Benzinga noted last June that five stocks accounted for more than half of MTUM’s year-to-date return, and CNBC reported in February 2026 that Bank of America and JPMorgan called an earlier MTUM drawdown “one of the worst one-day moves in years.” Zacks warned on June 27, 2026 that “momentum strategies can experience sudden reversals, especially after market sell-offs.”
The July setup looks unfriendly
The macro backdrop is not helping. The 10-year Treasury sits at 4.48% and rising, which pressures high-multiple growth names. The 2s10s spread has compressed to 0.35%, the fourth percentile of the past year.
Flattening curves historically push money out of momentum and into value and defensives. Meanwhile the VIX is under 16, in the lower quartile of the twelve-month range. That is the volatility equivalent of a heart rate too calm before a stress test. It spikes fast when it spikes.
The tradeoffs you actually sign up for
- Concentration you cannot control. The May and November rebalances rotate the book toward whatever just worked. You cannot request a less crowded portfolio.
- Beta amplification. MTUM rallies harder than the S&P 500 on risk-on days and falls harder on risk-off days. The May 9, 2026 drawdown described by Sahm Capital as MTUM’s worst daily decline since March is the shape of the risk.
- Income is a rounding error. The trailing yield is roughly 0.88%. This is a capital appreciation vehicle.
Who should own it, and how much
MTUM works as a tactical satellite. Sizing it above 5% to 10% of an equity allocation turns your portfolio into a bet on whatever theme is currently winning, which right now is AI infrastructure. If you want core large-cap exposure with a factor tilt at lower drama, a broad S&P 500 index fund pairs better with a value or quality sleeve.
Retirees, income investors, and anyone who cannot stomach a fast 7% weekly drawdown should look elsewhere. If you already own MTUM at a full weight going into July, the real question is whether you bought a factor strategy or just a leveraged chip trade wearing a suit.
Contact [email protected] for any questions or corrections.
Top Gaining Stocks
Top Losing Stocks